Vitrivax

Discovery Tools (Healthcare) · Boulder, CO · Founded 2014 · Privately Held (backing)

Developer of thermostable vaccine formulations designed to eliminate barriers to global vaccination. Vitrivax is based in Boulder, CO and was founded in 2014. It was valued at $69.4 million at its later-stage round in Nov 2025, the last priced event on record. It has raised $38.2 million across 1 recorded round; the latest was a $29.4 million Series B in Nov 2025.

PMV mark · valuation
$69.4M
Oct 2026
Priced at
its later-stage round
Nov 2025
Total raised
$38.2M
Last round
Later Stage VC (Series B)
Nov 2025
How much has Vitrivax raised?
$38.2Macross 1 recorded rounds · Nov 2025 – Nov 2025

Most recently, Vitrivax raised $29.4M in its Later Stage VC (Series B) (Nov 2025).

Free account
More of Vitrivax with a free account
  • ·The complete investor list: 15 names
  • ·Watch Vitrivax: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Vitrivax round by round

1 rounds
Nov 2025Later Stage VC (Series B)$29.4M▮
+ 1 more investors · free account

How much has Vitrivax raised?

Vitrivax has raised $38.2 million in total; 1 of its rounds is on record. The largest on record was a $29.4 million Series B in Nov 2025.

Vitrivax has filed 1 Form D with the SEC, most recently in Nov 2025 ($29.4 million sold to 83 investors).

Vitrivax investors

15 investors are on record for Vitrivax, including RA Capital Management, Gates Foundation, Fox Ventures and Colorado Office of Economic Development & International Trade. The Series B in Nov 2025 drew 1 investor.

For fundraisers
Raising for a company like Vitrivax?

15 investors have backed Vitrivax — start your target list with the firms already writing checks in discovery tools (healthcare).

See all 15 investors →

Frequently asked about Vitrivax

How much has Vitrivax raised?
Vitrivax has raised $38.2M in total across 1 recorded funding rounds.
When was Vitrivax's last funding round?
Vitrivax's most recent recorded round was Later Stage VC (Series B) in Nov 2025, raising $29.4M.